Technical Analysis for HOTH - Hoth Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
Fell Below 20 DMA | Bearish | 1.18% | |
Fell Below 50 DMA | Bearish | 1.18% | |
Calm After Storm | Range Contraction | 1.18% | |
Narrow Range Bar | Range Contraction | 1.18% | |
Gapped Down | Weakness | 1.18% | |
20 DMA Support | Bullish | -4.70% |
Alert | Time |
---|---|
10 DMA Support | about 21 hours ago |
Rose Above 10 DMA | about 21 hours ago |
Rose Above 20 DMA | about 24 hours ago |
20 DMA Support | about 24 hours ago |
Rose Above Previous Day's High | about 24 hours ago |
Get a Trading Assistant
- Earnings date: 11/11/2024
Hoth Therapeutics, Inc. Description
Hoth Therapeutics Inc., a Nevada corporation, is a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. Hoth has exclusive worldwide rights to the BioLexa Platform. Hoth intends to use the BioLexa Platform to develop two different topical cream products: (i) a product to treat eczema and (ii) a product that reduces post-procedure infections, accelerates healing and improves clinical outcomes for patients undergoing aesthetic dermatology procedures. Hoth’s initial focus will be on the development of the BioLexa Platform for the treatment of eczema. Eczema is a disease that results in inflammation of the skin and is characterized by rash, red skin, and itchiness. Eczema is also referred to as atopic dermatitis.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Disease Immunology Inflammation Dermatology Atopic Dermatitis Healing Dermatitis Type I Hypersensitivity Atopy Eczema Itchiness Sodium Hypochlorite Washes
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.725 |
52 Week Low | 0.58 |
Average Volume | 4,489,215 |
200-Day Moving Average | 1.06 |
50-Day Moving Average | 0.89 |
20-Day Moving Average | 0.86 |
10-Day Moving Average | 0.87 |
Average True Range | 0.10 |
RSI (14) | 48.98 |
ADX | 23.12 |
+DI | 36.96 |
-DI | 11.17 |
Chandelier Exit (Long, 3 ATRs) | 1.03 |
Chandelier Exit (Short, 3 ATRs) | 0.95 |
Upper Bollinger Bands | 0.97 |
Lower Bollinger Band | 0.74 |
Percent B (%b) | 0.52 |
BandWidth | 26.77 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0024 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.94 | ||||
Resistance 3 (R3) | 0.95 | 0.93 | 0.93 | ||
Resistance 2 (R2) | 0.93 | 0.91 | 0.93 | 0.92 | |
Resistance 1 (R1) | 0.89 | 0.90 | 0.88 | 0.89 | 0.92 |
Pivot Point | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
Support 1 (S1) | 0.84 | 0.85 | 0.83 | 0.83 | 0.80 |
Support 2 (S2) | 0.82 | 0.84 | 0.82 | 0.80 | |
Support 3 (S3) | 0.79 | 0.82 | 0.79 | ||
Support 4 (S4) | 0.78 |